Posted in | News | Gold | Mining Business

Roxgold Receives Final Permitting Approval for Yaramoko Gold Project

Roxgold Inc. ("Roxgold" or "the Company") is pleased to announce that it has received its final permitting approval for the Yaramoko Gold Project from the government of Burkina Faso.

The issuance of the Exploitation (Mining) Permit, which was previously approved by Burkina Faso's Council of Ministers, has now been finalized through the endorsement of the Mining Decree by the President of Burkina Faso, and other governmental authorities. The Mining Decree formally grants the Company rights to develop and operate the Yaramoko Gold Project.

"We are delighted to announce the formal conclusion of our permitting process, and to move our focus to the development of the Yaramoko Gold Project, one of the highest grade undeveloped deposits in the world," said John Dorward, President and CEO. "We thank the government of Burkina Faso for its demonstrated support, and look forward to a lasting and mutually beneficial partnership."

The Company expects to commence initial site works in the coming weeks and looks forward to providing further updates as development progresses.

About Roxgold
Roxgold is a gold exploration and development company with its key asset, the high grade Yaramoko Gold Project, located in the Houndé greenstone region of Burkina Faso, West Africa. The Company is currently advancing Yaramoko's 55 Zone and subject to making a positive construction decision expects to commence development in Q1 2015. Roxgold trades on the TSX Venture Exchange under the symbol ROG.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.